Product image of Helidiag (13c-Urea) supplied by GNH India

Helidiag

Active Ingredient:
13c-Urea
Origin:
EU

Helidiag (13c-Urea)

Helidiag is a pharmaceutical product that contains the active ingredient 13c‑Urea. It is marketed in the European Union and is supplied for oral use. The exact dosage form and strength have not been publicly disclosed, and the product is listed without a specific drug class or ATC code. Helidiag is intended for investigational or therapeutic purposes pending further clinical evaluation as part of clinical studies and research.

Manufacturer / TM Owner

Laboratoires Mayoly Spindler

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Publicly available sources do not list specific therapeutic indications for Helidiag. Potential areas of investigation include:

  • Investigational use in metabolic research
  • Potential adjunct in renal function studies
  • Exploratory application in nitrogen balance modulation
  • Research on urea metabolism disorders

Side Effects

Side‑effect information for Helidiag is limited. Reported events are based on general observations of oral urea compounds.

Common

  • Mild gastrointestinal discomfort
  • Nausea or upset stomach
  • Transient headache
  • Slight dizziness
  • Temporary metallic taste

Serious

  • Allergic reaction (rash, itching, swelling)
  • Severe skin eruption or hives
  • Anaphylaxis (rare)
  • Significant respiratory difficulty
  • Acute kidney injury (in predisposed individuals)

Precautions & Warnings

Helidiag should be used with caution and under professional supervision. Key safety considerations include:

  • Use only under medical guidance, especially in clinical studies
  • Pregnancy and lactation status have not been established; avoid use unless advised
  • Renal impairment may alter clearance; monitor kidney function
  • Monitor liver function during prolonged use
  • Avoid if known hypersensitivity to urea or related compounds
  • Do not exceed any recommended amount provided by a healthcare professional
  • Store at controlled room temperature, protected from moisture

Avoid Interactions

Potential drug interactions for Helidiag are not fully characterized. Known considerations are:

Avoid

  • Concurrent use with high‑dose diuretics that may affect electrolyte balance
  • Combination with other nitrogenous compounds that could alter metabolic pathways

Use with caution

  • Possible interaction with antihypertensive agents affecting blood pressure control
  • May interfere with laboratory tests measuring serum urea or nitrogen levels
  • Concurrent use with nephrotoxic agents should be monitored closely

Frequently Asked Questions

Helidiag is a pharmaceutical product marketed in the European Union that contains the active ingredient 13c‑Urea and is intended for oral administration.

The active ingredient in Helidiag is 13c‑Urea, a chemically distinct form of urea.

Helidiag is designed for oral use, meaning it is taken by mouth in the form provided by the manufacturer.

The regulatory status of Helidiag (prescription vs. over‑the‑counter) has not been publicly disclosed, so it should be obtained under medical supervision.

Current information suggests Helidiag may be investigated for metabolic research, renal function studies, nitrogen balance modulation, and urea metabolism disorders.

Commonly reported effects include mild gastrointestinal discomfort, nausea, transient headache, slight dizziness, and a temporary metallic taste.

Serious reactions that have been noted in limited reports include allergic skin reactions, anaphylaxis, significant respiratory difficulty, and potential acute kidney injury in susceptible individuals.

Precautions include using the product only under medical guidance, avoiding use during pregnancy or lactation unless advised, monitoring kidney and liver function, and not exceeding any recommended amount.

Potential interactions may occur with high‑dose diuretics, other nitrogenous compounds, antihypertensive drugs, and nephrotoxic agents, and it may affect laboratory tests for urea.

Helidiag should be stored at controlled room temperature, protected from moisture, and kept out of reach of children.

Specific details about the dosage form and strength of Helidiag have not been publicly disclosed.

Additional information may be available through clinical trial registries, regulatory agency publications, or peer‑reviewed research articles focusing on 13c‑Urea.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing 13c-Urea

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT